N
Niels Mejer
Researcher at University of Copenhagen
Publications - 14
Citations - 242
Niels Mejer is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Population & Comorbidity. The author has an hindex of 8, co-authored 14 publications receiving 196 citations. Previous affiliations of Niels Mejer include Copenhagen University Hospital & Hvidovre Hospital.
Papers
More filters
Journal ArticleDOI
Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008
Niels Mejer,Henrik Westh,Henrik Westh,Henrik Carl Schønheyder,Allan Jensen,Allan Jensen,Anders Rhod Larsen,Robert Skov,Thomas Benfield,Thomas Benfield +9 more
TL;DR: Throughout a 14-year period the overall incidence of SAB remained stable while the overall short term prognosis continued to improve despite increased age and accumulation of comorbidity in the cohort, however, age and comorbridity were strong prognostic indicators for short term mortality.
Journal ArticleDOI
A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia
Lothar Wiese,Niels Mejer,Henrik Carl Schønheyder,Henrik Westh,Henrik Westh,Allan Jensen,Anders Rhod Larsen,Robert Skov,Thomas Benfield,Thomas Benfield +9 more
TL;DR: Patients with previous SAB have a 60-fold higher risk of SAB compared to the general population, and patients with HIV infection, renal disease, diabetes, liver disease, peptic ulcer and paraplegia had the highest rates of reinfection.
Journal ArticleDOI
Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study.
Nanja Gotland,Nanja Gotland,M.L. Uhre,M.L. Uhre,Niels Mejer,Niels Mejer,Robert Skov,Andreas Petersen,Anders Rhod Larsen,Thomas Benfield,Thomas Benfield +10 more
TL;DR: Long-term mortality after SAB was high but decreased over time, and patients should be screened for comorbidity associated with SAB to improve long-term survival.
Journal ArticleDOI
Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection.
Ditte Marie Kirkegaard-Klitbo,Niels Mejer,Troels Bygum Knudsen,Holger Jon Møller,Søren K. Moestrup,Susanne D. Poulsen,Gitte Kronborg,Gitte Kronborg,Thomas Benfield,Thomas Benfield +9 more
TL;DR: In this article, the authors examined the associations between plasma-soluble CD163 (sCD163) and incident non-AIDS comorbidities in well treated HIV-infected individuals.
Journal ArticleDOI
Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Niels Mejer,Henrik Westh,Henrik Westh,Henrik Carl Schønheyder,Allan Jensen,Allan Jensen,Anders Rhod Larsen,Robert Skov,Thomas Benfield,Thomas Benfield +9 more
TL;DR: In this article, the authors examined the risk of venous thromboembolism after Staphylococcus aureus bacteraemia (SAB) compared to the risk in control subjects.